phenylacetic dipalmitate has been researched along with empagliflozin in 1 studies
| Studies (phenylacetic dipalmitate) | Trials (phenylacetic dipalmitate) | Recent Studies (post-2010) (phenylacetic dipalmitate) | Studies (empagliflozin) | Trials (empagliflozin) | Recent Studies (post-2010) (empagliflozin) |
|---|---|---|---|---|---|
| 7 | 1 | 5 | 1,429 | 313 | 1,395 |
| Protein | Taxonomy | phenylacetic dipalmitate (IC50) | empagliflozin (IC50) |
|---|---|---|---|
| Sodium/glucose cotransporter 2 | Homo sapiens (human) | 0.0031 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gosch, KL; Jones, P; Khariton, Y; Kosiborod, MN; Nassif, ME; Nguyen, D; Sauer, AJ; Spertus, JA; Tang, F; Windsor, SL | 1 |
1 trial(s) available for phenylacetic dipalmitate and empagliflozin
| Article | Year |
|---|---|
Association Between Change in Ambulatory Pulmonary Artery Pressures and Natriuretic Peptides in Patients with Heart Failure: Results From the EMBRACE-HF Trial.
Topics: Aged; Biomarkers; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pulmonary Artery | 2023 |